Article
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis.
Journal of neuroimmunology - 15 Apr 2017
Buttari Fabio, Zagaglia Sara, Marciano Lorenzo, Albanese Maria, Landi Doriana, Nicoletti Carolina Gabri, Mercuri Nicola Biagio, Silvestrini Mauro, Provinciali Leandro, Marfia Girolama Alessandra, Mori Francesco, Centonze Diego
Abstract excerpt
Interferon-β (IFN-β) is often discontinued in RRMS patients due to its most common side effect, the flu-like syndrome (FLS). The mechanisms underlying IFN β-induced FLS symptoms are still unclear. The endocannabinoid system (ECS) is a key regulator of pain and inflammation. Thus we tested the hypothesis that the ECS could be involved in FLS severity by exploring the effect of genetic polymorphisms with functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
